Publication:
A Rare Entity in Multiple Myeloma: Six Nerve Paralysis

Simple item page
dc.contributor.authorÇETİN, GÜVEN
dc.contributor.authorAR, Muhlis Cem
dc.contributor.authorCerit, Abdullah
dc.contributor.authorGozubenli, Kubra
dc.contributor.authorErdem, Simge
dc.contributor.authorHalac, Gulistan
dc.contributor.institutionauthorÇETİN, GÜVEN
dc.date.accessioned2020-10-22T18:32:02Z
dc.date.available2020-10-22T18:32:02Z
dc.date.issued2014-09-01T00:00:00Z
dc.description.abstractOphthalmic involvement appears rarely in multiple myeloma (MM). Ophthalmic findings are mostly noted as complications caused by disease or treatment. MM-associated with 6th nerve paralysis is a rare entity. Bortezomib, one of the novel agents used to treat MM, has neurotoxic effect and may cause permanent nerve damage. Herein, we report a 50-year-old male patient with MM who developed the 6th nerve paralysis while receiving bortezomib and discuss its relevant causes.
dc.identifier.citationÇETİN G., AR M. C. , Cerit A., Gozubenli K., Erdem S., Halac G., -A Rare Entity in Multiple Myeloma: Six Nerve Paralysis-, INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, cilt.30, 2014
dc.identifier.doi10.1007/s12288-013-0252-5
dc.identifier.pubmed25332540
dc.identifier.scopus84924814539
dc.identifier.urihttp://hdl.handle.net/20.500.12645/24099
dc.identifier.urihttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4192163/
dc.identifier.wosWOS:000343724300022
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectNerve paralysis
dc.titleA Rare Entity in Multiple Myeloma: Six Nerve Paralysis
dc.typeArticle
dspace.entity.typePublication
local.avesis.id8483f47e-3ffb-40a9-aee8-ea4908142e5b
local.publication.isinternational1
relation.isAuthorOfPublicationb08a3f06-950e-41ba-bd74-ae73d014adc9
relation.isAuthorOfPublication.latestForDiscoveryb08a3f06-950e-41ba-bd74-ae73d014adc9
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
a rare entity.pdf
Size:
348.2 KB
Format:
Adobe Portable Document Format
Description:
Download
Collections
Yayınlar - Eserler